106 related articles for article (PubMed ID: 27558500)
1. Follow-up over 20 months confirms gains of online behavioural training in frequent episodic migraine.
Sorbi MJ; Balk Y; Kleiboer AM; Couturier EG
Cephalalgia; 2017 Mar; 37(3):236-250. PubMed ID: 27558500
[TBL] [Abstract][Full Text] [Related]
2. Medium-term effectiveness of online behavioral training in migraine self-management: A randomized trial controlled over 10 months.
Sorbi MJ; Kleiboer AM; van Silfhout HG; Vink G; Passchier J
Cephalalgia; 2015 Jun; 35(7):608-18. PubMed ID: 25228685
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of home-based behavioral management training provided by migraine patients.
Voerman JS; Klerk Cd; Mérelle SY; Aartsen E; Timman R; Sorbi MJ; Passchier J
Cephalalgia; 2014 Apr; 34(5):357-64. PubMed ID: 24326237
[TBL] [Abstract][Full Text] [Related]
4. Short-term effectiveness of an online behavioral training in migraine self-management: a randomized controlled trial.
Kleiboer A; Sorbi M; van Silfhout M; Kooistra L; Passchier J
Behav Res Ther; 2014 Oct; 61():61-9. PubMed ID: 25133856
[TBL] [Abstract][Full Text] [Related]
5. Lay trainers with migraine for a home-based behavioral training: a 6-month follow-up study.
Mérelle SY; Sorbi MJ; van Doornen LJ; Passchier J
Headache; 2008 Oct; 48(9):1311-25. PubMed ID: 19031498
[TBL] [Abstract][Full Text] [Related]
6. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of a web-based intervention to improve migraine self-management and coping.
Bromberg J; Wood ME; Black RA; Surette DA; Zacharoff KL; Chiauzzi EJ
Headache; 2012 Feb; 52(2):244-61. PubMed ID: 22413151
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
[TBL] [Abstract][Full Text] [Related]
9. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
10. Randomized Controlled Pilot Trial of Behavioral Insomnia Treatment for Chronic Migraine With Comorbid Insomnia.
Smitherman TA; Walters AB; Davis RE; Ambrose CE; Roland M; Houle TT; Rains JC
Headache; 2016 Feb; 56(2):276-91. PubMed ID: 26813845
[TBL] [Abstract][Full Text] [Related]
11. Qualities and health of lay trainers with migraine for behavioral attack prevention.
Mérelle SY; Sorbi MJ; Duivenvoorden HJ; Passchier J
Headache; 2010 Apr; 50(4):613-25. PubMed ID: 20456149
[TBL] [Abstract][Full Text] [Related]
12. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache.
Moscano F; Guiducci M; Maltoni L; Striano P; Ledda MG; Zoroddu F; Raucci U; Villa MP; Parisi P
Ital J Pediatr; 2019 Mar; 45(1):36. PubMed ID: 30871574
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
14. A self-administered behavioral intervention using tailored messages for migraine.
Nicholson R; Nash J; Andrasik F
Headache; 2005 Oct; 45(9):1124-39. PubMed ID: 16178943
[TBL] [Abstract][Full Text] [Related]
15. The course of frequent episodic migraine in a large headache clinic population: a 12-year retrospective follow-up study.
Dahlöf CG; Johansson M; Casserstedt S; Motallebzadeh T
Headache; 2009 Sep; 49(8):1144-52. PubMed ID: 19719542
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
17. Effects of Botulinum Toxin on Migraine Attack Features in Chronic Migraine: A Six-Month Open-Label Observation Study through Electronic Diary Smartphone Application.
Santoro A; Delussi M; Leone M; Miscio AM; De Rocco L; Leo G; De Tommaso M
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31731628
[TBL] [Abstract][Full Text] [Related]
18. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric disorders and muscle tenderness in episodic and chronic migraine.
Mongini F; Deregibus A; Rota E
Expert Rev Neurother; 2005 Sep; 5(5):635-42. PubMed ID: 16162087
[TBL] [Abstract][Full Text] [Related]
20. Duration of migraine is a predictor for response to botulinum toxin type A.
Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
